TELA Bio (TELA) Cash from Investing Activities (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.04% |
| Dec 31, 2025 | -38.46% |
| Sep 30, 2025 | 52.94% |
| Jun 30, 2025 | 47.83% |
| Mar 31, 2025 | 172.63% |
| Dec 31, 2024 | -55.74% |
| Sep 30, 2024 | -282.09% |
| Jun 30, 2024 | -98.57% |
| Mar 31, 2024 | 2,533.16% |
| Dec 31, 2023 | -44.03% |
| Sep 30, 2023 | 14.65% |
| Jun 30, 2023 | -36.52% |
| Mar 31, 2023 | 89.01% |
| Dec 31, 2022 | -260.69% |
| Sep 30, 2022 | -45.00% |
| Jun 30, 2022 | 40.48% |
| Mar 31, 2022 | -16.26% |
| Dec 31, 2021 | 0.69% |
| Sep 30, 2021 | -1,064.00% |
| Jun 30, 2021 | -13.64% |
| Mar 31, 2021 | 42.11% |
| Dec 31, 2020 | -15.15% |
| Sep 30, 2020 | -100.63% |
| Jun 30, 2020 | 33.80% |
| Mar 31, 2020 | 142.20% |
| Dec 31, 2019 | -349.01% |
| Sep 30, 2019 | -4,960.98% |
| Jun 30, 2019 | 92.52% |
| Mar 31, 2019 | 63.85% |